These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The influence of vasodilating beta-blockers on cardiac function and vascular resistance in essential hypertension. Lund-Johansen P. Clin Nephrol; 1992; 38 Suppl 1():S78-86. PubMed ID: 1363538 [Abstract] [Full Text] [Related]
12. The role of multiple action agents in hypertension. Lund-Johansen P, Omvik P. Eur J Clin Pharmacol; 1990; 38 Suppl 2():S89-95. PubMed ID: 1974512 [Abstract] [Full Text] [Related]
13. Experimental and clinical pharmacology of carvedilol and other drugs combining vasodilation and beta-adrenoceptor antagonism in a single molecule. Strein K, Sponer G. Z Kardiol; 1990; 79 Suppl 3():89-98. PubMed ID: 1983054 [Abstract] [Full Text] [Related]
16. Effects of dilevalol on rest and supine exercise hemodynamics in mild to moderate systemic hypertension. Bugni WJ, Ayers CW, Ashby R, Bittle PA, Ramirez G. Am J Cardiol; 1989 Feb 15; 63(7):452-6. PubMed ID: 2563624 [Abstract] [Full Text] [Related]
17. Cardiovascular dynamics after acute and long-term alpha- and beta-adrenoceptor blockade at rest, supine and standing, and during exercise. Koch G. Br J Clin Pharmacol; 1979 Feb 15; 8(Suppl 2):101S-105S. PubMed ID: 43162 [Abstract] [Full Text] [Related]
18. The vasodilatory beta-blockers. Pedersen ME, Cockcroft JR. Curr Hypertens Rep; 2007 Aug 15; 9(4):269-77. PubMed ID: 17686376 [Abstract] [Full Text] [Related]